- Generic name
- Ferric Carboxymaltose
- Strength
- 1000 mg/20 ml
- Dosage form
- Injection
- Manufactured by
- Nuvista Pharma Ltd
Hemoject 1 IV Injection Injection
About Hemoject 1 IV Injection 1000 mg/20 ml
Hemoject 1 IV Injection is an iron replacement given by a healthcare professional. It helps rebuild iron stores when iron is low and the body cannot get enough from tablets or diet.
There are 15 brands of Ferric Carboxymaltose listed in Bangladesh. The lowest listed price is Ferium Injection 500 mg/10 ml at ৳ 700 per unit.
What is Hemoject 1 IV Injection 1000 mg/20 ml?
This medicine is a parenteral iron preparation, meaning iron is delivered into the body through a vein rather than by mouth. Its active substance is ferric carboxymaltose, a complex that releases iron gradually so the body can use it to rebuild iron stores. Iron is needed to make haemoglobin, the part of red blood cells that carries oxygen. The injection is used when oral iron is not tolerated or has not worked well, and in some adults with non-dialysis dependent chronic kidney disease. Hemoject 1 IV Injection comes as a 1000 mg/20 ml strength in injection form and is given only in a supervised clinical setting.
Uses of Hemoject 1 IV Injection
Hemoject 1 IV Injection is used to treat iron deficiency anaemia in adults. It is intended for people who cannot tolerate iron taken by mouth or who have not responded well to oral iron. It is also used in adults with non-dialysis dependent chronic kidney disease who have iron deficiency anaemia. The doctor confirms the need for iron replacement before prescribing it.
How to use Hemoject 1 IV Injection
This injection is given by a doctor or trained healthcare professional into a vein. You should not self-administer it. The doctor decides the dose, the number of doses and the course, based on your weight, your iron needs and your response. Doses are separated by an interval set by the doctor. Tell the clinical team about any reaction during or after the infusion, and follow their instructions for monitoring.
Side effects of Hemoject 1 IV Injection
Some people may experience nausea, vomiting, headache, dizziness, flushing, itching, rash, hives, wheezing, constipation, low blood pressure or a change in taste. The injection site may become discoloured. Blood phosphorus and liver enzyme levels can change, and blood pressure may rise. Serious allergic-type reactions, including severe ones, have been reported. Seek urgent help if you feel faint, have trouble breathing or notice swelling. Ask your doctor about any side effect that worries you.
Safety and precautions
Tell your doctor before treatment if you have had an allergic reaction to iron products or to any ingredient in this injection. Serious hypersensitivity reactions can occur, so the infusion is given where monitoring and emergency treatment are available; the clinical team watches you during and after administration. This medicine is in pregnancy category C, meaning animal studies showed adverse effects on the fetus and human data are limited, so a doctor will weigh the benefits and risks. Ask your doctor first if you are pregnant, planning pregnancy or breastfeeding, or if you have other health conditions or take other medicines.
Frequently asked questions
What is Hemoject 1 IV Injection used for and what kind of medicine is it?
It is a parenteral iron preparation, meaning iron is given into a vein. It treats iron deficiency anaemia in adults who cannot tolerate oral iron, do not respond well to it, or have non-dialysis dependent chronic kidney disease. Your doctor will confirm whether it is suitable for you.
How is Hemoject 1 IV Injection taken?
It is given into a vein by a doctor or trained healthcare professional, not at home. The doctor decides the dose, how many doses you need and the gap between them, based on your weight and iron needs. Follow the clinical team's instructions and report any reaction.
What do the injection form and the 1000 mg/20 ml strength mean?
The injection form means the medicine is delivered into a vein in a clinical setting. The strength, 1000 mg/20 ml, describes how much active substance is present in the vial as supplied by the manufacturer. It is not a dose for you to use; the doctor decides how much you receive.
What should I tell my doctor before receiving this injection?
Tell your doctor about any previous allergic reaction to iron or to any ingredient, and about other medicines or health conditions you have. Mention if you are pregnant, planning pregnancy or breastfeeding. The doctor will decide whether this treatment is appropriate for you.
Indications
- Who have intolerance to oral iron or have had unsatisfactory response to oral iron
- Who have non-dialysis dependent chronic kidney disease.
Pharmacology
Dosage & Administration
For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.
The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.
Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.
When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.
Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.
Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Hypertension: Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.
Storage Conditions
Alternative brands of Ferric Carboxymaltose
Other brands with the same generic name, cheapest first.
Ferox 15 ml IV Injection/Infus Injection
750 mg/15 ml
Advanced Chemical Industries PLC
Price not listed
Ferox 20 ml IV Injection/Infus Injection
1000 mg/20 ml
Advanced Chemical Industries PLC
Price not listed
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.